{"gao_id": "GAO-20-233", "published": "2020-01-24T12:00:00Z", "released": "2020-01-24T07:00:00Z", "summary": "Nearly 2 million Americans misused or were addicted to opioids in 2018. Medication-assisted treatment\u2014which combines medications such as buprenorphine with behavioral therapy\u2014can effectively treat opioid use disorders and overdoses. Medicaid is one of the largest sources of coverage for individuals undergoing medication-assisted treatment. The Department of Health and Human Services has worked to increase access to the treatment. We identified state policies that can restrict...", "title": "Opioid Use Disorder: Barriers to Medicaid Beneficiaries' Access to Treatment Medications", "topics": ["Beneficiaries", "Patient care", "Compliance oversight", "Pharmacy", "Addiction", "Health Care", "Medicaid", "Controlled substances", "Prescription drugs", "Health care providers", "Physicians"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-20-233", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-20-233-highlights.pdf"}, {"title": "Full Report (35 pages)", "url": "https://www.gao.gov/assets/gao-20-233.pdf"}, {"title": "Accessible PDF (40 pages)", "url": "https://www.gao.gov/assets/710/706795.pdf"}]}